Arteris, Inc. (NASDAQ:AIP – Get Free Report) CEO K Charles Janac sold 4,583 shares of the stock in a transaction that occurred on Monday, July 1st. The stock was sold at an average price of $7.24, for a total value of $33,180.92. Following the sale, the chief executive officer now directly owns 310,758 shares of the company’s stock, valued at $2,249,887.92. The transaction was disclosed in a filing with the SEC, which is accessible through this link.
K Charles Janac also recently made the following trade(s):
- On Wednesday, July 3rd, K Charles Janac sold 9,168 shares of Arteris stock. The stock was sold at an average price of $7.23, for a total transaction of $66,284.64.
- On Tuesday, June 4th, K Charles Janac sold 3,303 shares of Arteris stock. The shares were sold at an average price of $7.70, for a total transaction of $25,433.10.
Arteris Price Performance
Shares of AIP stock opened at $7.21 on Friday. The firm’s fifty day moving average price is $7.83 and its two-hundred day moving average price is $6.96. The company has a current ratio of 1.24, a quick ratio of 1.24 and a debt-to-equity ratio of 0.11. Arteris, Inc. has a 1 year low of $4.20 and a 1 year high of $9.54. The firm has a market capitalization of $277.44 million, a P/E ratio of -7.00 and a beta of 1.11.
Institutional Investors Weigh In On Arteris
Several large investors have recently made changes to their positions in the stock. Silvercrest Asset Management Group LLC raised its position in Arteris by 25.2% during the first quarter. Silvercrest Asset Management Group LLC now owns 711,903 shares of the company’s stock worth $5,211,000 after acquiring an additional 143,385 shares in the last quarter. Acuitas Investments LLC increased its stake in shares of Arteris by 150.3% during the 4th quarter. Acuitas Investments LLC now owns 215,991 shares of the company’s stock worth $1,272,000 after purchasing an additional 129,692 shares during the last quarter. Acadian Asset Management LLC raised its holdings in shares of Arteris by 28.1% in the 1st quarter. Acadian Asset Management LLC now owns 534,472 shares of the company’s stock valued at $3,911,000 after purchasing an additional 117,312 shares during the period. Roubaix Capital LLC lifted its stake in Arteris by 34.5% in the 4th quarter. Roubaix Capital LLC now owns 342,664 shares of the company’s stock valued at $2,018,000 after purchasing an additional 87,920 shares during the last quarter. Finally, Worth Venture Partners LLC grew its holdings in Arteris by 114.3% during the fourth quarter. Worth Venture Partners LLC now owns 109,921 shares of the company’s stock worth $647,000 after purchasing an additional 58,620 shares during the period. Institutional investors and hedge funds own 64.36% of the company’s stock.
Analyst Upgrades and Downgrades
Several research firms have issued reports on AIP. Jefferies Financial Group reissued a “hold” rating and issued a $9.00 price target (down previously from $11.00) on shares of Arteris in a research note on Monday, May 13th. Rosenblatt Securities reissued a “buy” rating and issued a $15.00 target price on shares of Arteris in a research report on Friday, May 3rd. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $13.40.
View Our Latest Research Report on Arteris
About Arteris
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
See Also
- Five stocks we like better than Arteris
- How to Choose Top Rated Stocks
- Investing in Cooling Technologies: 3 Top Stocks to Beat the Heat
- What is the Hang Seng index?
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- Ride Out The Recession With These Dividend Kings
- AbbVie Stock: A Perfect Dip for Investors to Buy
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.